M. Carini

M. Carini

Auto-generated profile, based on publicly available information

M. Carini

Aouc Careggi Firenze , Florence , ITALY

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1992 in European Urology
Verified
Journal Article
Closed access
PDF file
MCM. Carini
M. Carini
SSS. Semi
S. Semi
SSS. Scelzi
S. Scelzi
ALA. Lapini
A. Lapini
CSC. Selli
C. Selli
GPG. Del Popolo
G. Del Popolo
Since January 1985, orthotopic ileal bladder substitution after radical cystectomy was performed in 64 male patients. The Carney I procedure was performed in 35 patients (group 1) and the Studer procedure in 29 (group 2). Clinical, metabolic and urodynamic evaluation was performed at regular intervals with a mean follow-up of 27 months for group 1 and 13.6 months for group 2. Patients wtih a Carney I bladder reconstruction presented smaller capacity and higher intraluminal pressure resulting in shorter voiding intervals and a practically uniform presence of enuresis, as opposed to those reconstructed with the Studer procedure. The incidence of ureteral reflux was also higher in group 1. Metabolic studies in both groups revealed a slight metabolic acidosis which was treated with oral akalinization. It is concluded that detubularization of the terminal ileum creates a more favorable low-pressure reservoir.

1 August 2002 in Urologia Internationalis
Verified
Journal Article
Closed access
PDF file
CCC. Corvino
C. Corvino
FBF. Balloni
F. Balloni
EME. Meliani
E. Meliani
AGA. Giannini
A. Giannini
SSS. Serni
S. Serni
MCM. Carini
M. Carini
Rapid testicular enlargement is usually strongly suggestive of tumor. Primary testicular infiltration due to amyloidosis is rare. We report a new case of primary testicular amyloidosis in a 72-year-old white man who presented with a short history of painless right testis enlargement.

1 April 2015 in Cancer Investigation
Verified
Journal Article
Closed access
BDB. Detti
B. Detti
PBPierluigi Bonomo
Pierluigi Bonomo
LML. Masi
L. Masi
RDR. Doro
R. Doro
SCS. Cipressi
S. Cipressi
LLLorenzo Livi
Lorenzo Livi
Cyberknife is an emerging treatment for early stage prostate cancer. Between October 2012 and January 2014, 32 patients were treated in our institution. Prescribed dose was 35-36.25 Gy in five fractions. Biochemical response was observed in 22 patients. Four patients experienced G2 acute genitourinary toxicity and in two cases we recorded G3 acute GU toxicity. 5 patients experienced G2 acute proctitis. At last follow up visit, all patients were still alive. 29 remained free of disease at last follow up appointment, while three developed a biochemical recurrence. Our experience confirms the efficacy and safety of Cyberknife for localized prostate cancer.

1 March 2017 in European Urology Supplements
Verified
Journal Article
Closed access
AMA. Minervini
A. Minervini
Andrea MariAndrea Mari
Andrea Mari
RCRiccardo Campi
Riccardo Campi
GNG. Novara
G. Novara
AAA. Antonelli
A. Antonelli
MCM. Carini
M. Carini

7 December 2003 in BJU International
Verified
Journal Article
Open access
PDF file
CCC. Corvino
C. Corvino
EME. Meliani
E. Meliani
LML. Masieri
L. Masieri
ALA. Lapini
A. Lapini
SSS. Serni
S. Serni
MCM. Carini
M. Carini

1 December 2001
Verified
Journal Article
Closed access
LPL Puccetti
L Puccetti
CUC Urso
C Urso
ALA Lapini
A Lapini
SSS Serni
S Serni
MCM Carini
M Carini